This is a match-making section for OHAMR Call for proposals 2026.
H - Human Health
drug delivery; nanoemulsions biofilm susceptibility test; wound
We are clinical microbiologists with extensive experience in medical mycology and evaluating the biological activity of smart materials for cutaneous drug delivery, including commercially available drugs and biocidal substances for the treatment of infected wounds and systemic infections. Our expertise includes cytotoxicity assays, wound-healing (scratch) assays, and studies using skin cell models (fibroblasts and keratinocytes). We also have strong experience in biofilm models involving clinically relevant pathogens, testing natural compounds and pharmacological agents for biofilm reduction, confocal microscopy analyses, and pilot in situ studies conducted in hospital settings.
We are interested in joining collaborative projects focused on the development and validation of smart or advanced biomaterials for the prevention and treatment of infected wounds and biofilm-associated infections. In particular, we aim to contribute to projects addressing localized drug delivery strategies that enhance antimicrobial efficacy while minimizing cytotoxicity and systemic exposure. Our interest includes translational studies combining material science with clinical microbiology, such as the evaluation of antimicrobial and antibiofilm activity, wound-healing performance, and biocompatibility in relevant in vitro and ex vivo skin models, with a clear pathway toward clinical implementation in hospital settings.
Submitted on 2025-12-16 08:09:00
« Return to the partner search tool